✦ LIBER ✦

Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently ‘normal’ alanine aminotransferase levels treated with peginterferon α-2a (40KD) plus ribavirin

✍ Scribed by Eric Snoeck; Stephanos J. Hadziyannis; Claudio Puoti; Mark G. Swain; Thomas Berg; Patrick Marcellin; Jean-Pierre Zarski; Karin Jorga; Stefan Zeuzem

Book ID: 111237772
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 480 KB
Volume: 28
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2007.01603.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of hepatitis C virus carriers

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α-2a and ribavirin: a multicentric study

✍ Claudio Puoti; Adriano M. Pellicelli; Mario Romano; Fabrizio Mecenate; Riccardo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

The economics of treating chronic hepati

The economics of treating chronic hepatitis C patients with peginterferon α-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase

✍ J. Hornberger; P. Farci; D. Prati; S. Zeuzem; J. Green; K. K. Patel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α-2a (40 kDa) plus ribavirin: Impact on health-related quality of life

✍ SANJEEV ARORA; CHRISTOPHER O'BRIEN; STEFAN ZEUZEM; MITCHELL L SHIFFMAN; MOISES D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Significance of hepatitis C virus coinfe

Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients

✍ L Fonquernie; L Serfaty; A Charrois; D Wendum; B Lefebvre; PM Girard; JL Meynard 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB